Praxis precision medicines to hold virtual investor event to discuss clinical programs in developmental and epileptic encephalopathies

Boston, april 08, 2025 (globe newswire) -- praxis precision medicines , inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be hosting a virtual investor event on friday, may 2, 2025 from 10:00 a.m. to 11:30 a.m. edt.
PRAX Ratings Summary
PRAX Quant Ranking